跳至主要内容
临床试验/CTRI/2025/06/088131
CTRI/2025/06/088131尚未招募4 期

To Study the Efficacy of Individualised Homoeopathic Medicines in Cases of Functional Dyspepsia :- A Single Blind, Randomized, Placebo-Controlled Trial

Dr Aastik Manojbhai Dandiwala1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年3月6日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
1 To See the Role of Individualized Homoeopathic Medicine in comparison with Placebo in Cases of Functional Dyspepsia

研究概览

简要总结

The Study is Single Blind , Randomized , Placebo Controlled Trial to Assess the Efficacy of Individualized Homoeopathic Medicine in Cases of Functional Dyspepsia. The Study will be Conducted in 80 participants which will be enrolled in Jawaharlal Nehru Homoeopathic Medical College Hospital, Vadodara, Gujarat, India. SF-LDQ Scale will be used for Assessment Purpose. The Study would be Conducted in Time Duration of 1 Year.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 45.00 Year(s)(—)

入选标准

  • a) Patients covering the diagnostic criteria for FUNCTIONAL DYSPEPSIA (ROME IV CRITERIA) b) Age – 20 to 45 years c) Gender – both male and female d) All socio- economic status e) Willing to give informed consent.

排除标准

  • a) Patients having Organic Gastrointestinal diseases.
  • b) Patient having IBS (irritable bowel syndrome).
  • c) Severe psychiatric disorders.
  • d) Patients with malignancies.
  • e) Pregnant and lactating females.

结局指标

主要结局

1 To See the Role of Individualized Homoeopathic Medicine in comparison with Placebo in Cases of Functional Dyspepsia

时间窗: 3 Months and Interim Analysis at 1.5 Months, if Necessary

2 To Assess the Severity & Outcome of Patients before & after treatment in cases of Functional Dyspepsia by using Short Form-Leeds Dyspepsia Questionnaire (SF-LDQ)

时间窗: 3 Months and Interim Analysis at 1.5 Months, if Necessary

3 To Emerge the Therapeutics of Functional Dyspepsia

时间窗: 3 Months and Interim Analysis at 1.5 Months, if Necessary

次要结局

  • 1 To Check & Verify the most common age group affected by this condition(2 To Find out the most frequently used Medicines)

研究者

发起方
Dr Aastik Manojbhai Dandiwala
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验